航天機電(600151.SH):控股子公司埃斯創韓國擬清算註銷其常熟子公司
格隆匯11月22日丨航天機電(600151.SH)公佈,公司控股子公司埃斯創韓國於2017年11月設立了埃斯創(常熟)汽車系統有限公司(簡稱“埃斯創韓國常熟”),在中國境內從事熱交換業務。截至目前,埃斯創韓國常熟一直維持着無實際業務運營的狀態。公司董事會同意公司控股子公司埃斯創韓國清算註銷埃斯創韓國常熟。埃斯創韓國常熟未直接從事經營業務,不存在需要清理的應收賬款,不存在員工安置問題。公司不存在為埃斯創韓國常熟提供擔保、委託理財、提供財務資助的情形,埃斯創韓國常熟不存在佔用公司資金的情形。該事項不會對公司業務經營產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.